{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:52:43Z","timestamp":1781617963420,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the proven efficacy of HIV pre-exposure prophylaxis (PrEP), adequate awareness and positive perception among women in sub-Saharan Africa (SSA) remain poorly understood, limiting uptake. Existing studies are largely country-specific, focus on limited socio-demographic factors, and rarely leverage advanced analytical methods to identify key determinants. This study addresses these gaps by applying machine learning to population-based surveys across multiple SSA countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed nationally representative surveys from eight SSA countries conducted between 2021 and 2024, including 123,132 HIV negative women aged 15\u201349 years. Primary outcomes were adequate awareness and positive perception of PrEP. Predictor variables included socio-demographic characteristics, behavioral factors, healthcare utilization, and contextual features. Data preprocessing included multiple imputation, one-hot encoding, and min\u2013max scaling. Recursive feature elimination and correlation analysis guided feature selection. Five machine learning models\u2014KNN, XGBoost, CatBoost, LightGBM, and Gradient Boosting\u2014were trained and evaluated using accuracy, precision, recall, F1-score, and ROC AUC. SHAP values provided interpretable insights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only 14.9% of women demonstrated adequate awareness and positive perception of PrEP, with marked variation across countries (5.6% in Tanzania to 73.6% in Lesotho). Younger age (15\u201324 years), lower education, limited media exposure, and minimal healthcare engagement were strongly associated with inadequate awareness. CatBoost outperformed other models (accuracy 0.91, F1-score 0.88), followed by XGBoost (accuracy 0.89, F1-score 0.86). SHAP analysis confirmed age, education, media exposure, healthcare visits, and marital status as the most influential predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adequate awareness and positive perception of PrEP among women in SSA remains inadequate and unevenly distributed, highlighting urgent gaps in education and outreach. Machine learning effectively identifies key drivers, enabling targeted interventions to improve PrEP uptake across diverse socio-demographic contexts. These findings can inform country-specific PrEP awareness campaigns and policy strategies to enhance HIV prevention efforts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12032-9","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:14:25Z","timestamp":1763136865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Machine learning to examine adequate awareness and positive perception of HIV pre-exposure prophylaxis among women in sub-Saharan Africa: evidence from 2021-2024 surveys"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-0999","authenticated-orcid":false,"given":"Bewuketu","family":"Terefe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Keffale","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andualem Enyew","family":"Gedefaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliyas Addisu","family":"Taye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fentahun Bikale","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilu","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebebe Demis","family":"Baykemagn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirualem Zeleke","family":"Yehuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanuel","family":"Worku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"12032_CR1","doi-asserted-by":"publisher","first-page":"1079990","DOI":"10.3389\/fpubh.2023.1079990","volume":"11","author":"E Moyo","year":"2023","unstructured":"Moyo E, Moyo P, Murewanhema G, Mhango M, Chitungo I, Dzinamarira T. Key populations and Sub-Saharan africa\u2019s HIV response. Front Public Health. 2023;11:1079990.","journal-title":"Front Public Health"},{"key":"12032_CR2","unstructured":"HIV.gov. Global Health Statistics: https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/global-statistics\/. 2023."},{"key":"12032_CR3","unstructured":"2025 UNAIDS. FACT SHEET, Global. HIV statistics: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf. 2025."},{"key":"12032_CR4","doi-asserted-by":"publisher","first-page":"1376235","DOI":"10.3389\/fpubh.2024.1376235","volume":"12","author":"A Gedefie","year":"2025","unstructured":"Gedefie A, Muche A, Mohammed A, Ayres A, Melak D, Abeje ET, et al. Prevalence and determinants of HIV among reproductive-age women (15\u201349 years) in Africa from 2010 to 2019: a multilevel analysis of demographic and health survey data. Front Public Health. 2025;12:1376235.","journal-title":"Front Public Health"},{"issue":"1","key":"12032_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1186\/s12889-024-18717-1","volume":"24","author":"B Terefe","year":"2024","unstructured":"Terefe B, Jembere MM, Asgedom DK, Lakew AM. Knowledge and attitude to HIV pre exposure prophylaxis among women in five sub-saharan African countries: a multilevel model analysis of population-based survey 2021\u20132022. BMC Public Health. 2024;24(1):1253.","journal-title":"BMC Public Health"},{"issue":"1","key":"12032_CR6","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1186\/s12889-024-19529-z","volume":"24","author":"B Terefe","year":"2024","unstructured":"Terefe B, Jembere MM, Reda GB, Asgedom DK, Assefa SK, Lakew AM. Knowledge, and utilization of HIV self-testing, and its associated factors among women in sub\u2013Saharan africa: evidence from 21 countries demographic and health survey. BMC Public Health. 2024;24(1):1960.","journal-title":"BMC Public Health"},{"key":"12032_CR7","unstructured":"UNAIDS. HIV in Kenya. A PrEP and voluntary medical male circumcision leader: https:\/\/www.avert.org\/professionals\/hiv-aroundworld\/sub-saharan-africa\/kenya. 2021."},{"issue":"1","key":"12032_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-6405-10-30","volume":"10","author":"G Ramjee","year":"2013","unstructured":"Ramjee G, Daniels B. Women and HIV in sub-Saharan Africa. AIDS Res Therapy. 2013;10(1):1\u20139.","journal-title":"AIDS Res Therapy"},{"issue":"2","key":"12032_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0956247806069624","volume":"18","author":"R Mabala","year":"2006","unstructured":"Mabala R. From HIV prevention to HIV protection: addressing the vulnerability of girls and young women in urban areas. Environ Urbanization. 2006;18(2):407\u201332.","journal-title":"Environ Urbanization"},{"key":"12032_CR10","unstructured":"HIV\/AIDS JUNPo. Women out loud: how women living with HIV will help the world end AIDS. 2012."},{"issue":"2","key":"12032_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/073993302753429031","volume":"23","author":"L Ackermann","year":"2002","unstructured":"Ackermann L, Klerk GW. Social factors that make South African women vulnerable to HIV infection. Health Care Women Int. 2002;23(2):163\u201372.","journal-title":"Health Care Women Int"},{"key":"12032_CR12","doi-asserted-by":"crossref","unstructured":"Bekker L-G, Giovenco D, Baral S, Dominguez K, Valencia R, Sanchez T et al. Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women. Southern J HIV Med. 2022;23(1).","DOI":"10.4102\/sajhivmed.v23i1.1405"},{"key":"12032_CR13","unstructured":"Antiretroviral TS. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015."},{"key":"12032_CR14","unstructured":"World Health Organization (WHO). Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 1: clinical. World Health Organization; 2017."},{"issue":"8","key":"12032_CR15","doi-asserted-by":"publisher","first-page":"e25588","DOI":"10.1002\/jia2.25588","volume":"23","author":"J Kagaayi","year":"2020","unstructured":"Kagaayi J, Batte J, Nakawooya H, Kigozi B, Nakigozi G, Str\u00f6mdahl S, et al. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South\u2010Central Uganda. J Int AIDS Soc. 2020;23(8):e25588.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"12032_CR16","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973.","journal-title":"AIDS"},{"key":"12032_CR17","doi-asserted-by":"crossref","unstructured":"Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: potential barriers to PrEP uptake among US women. J AIDS Clin Res. 2017;8(9).","DOI":"10.4172\/2155-6113.1000730"},{"issue":"11","key":"12032_CR18","doi-asserted-by":"publisher","first-page":"e0207650","DOI":"10.1371\/journal.pone.0207650","volume":"13","author":"I Kambutse","year":"2018","unstructured":"Kambutse I, Igiraneza G, Ogbuagu O. Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda. PLoS ONE. 2018;13(11):e0207650.","journal-title":"PLoS ONE"},{"issue":"11","key":"12032_CR19","doi-asserted-by":"publisher","first-page":"e1002444","DOI":"10.1371\/journal.pmed.1002444","volume":"14","author":"R Eakle","year":"2017","unstructured":"Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South africa: results from a prospective observational demonstration project. PLoS Med. 2017;14(11):e1002444.","journal-title":"PLoS Med"},{"issue":"9","key":"12032_CR20","doi-asserted-by":"publisher","first-page":"e011595","DOI":"10.1136\/bmjopen-2016-011595","volume":"6","author":"GB Gomez","year":"2016","unstructured":"Gomez GB, Eakle R, Mbogua J, Akpomiemie G, Venter WF, Rees H. Treatment and prevention for female sex workers in South africa: protocol for the TAPS demonstration project. BMJ Open. 2016;6(9):e011595.","journal-title":"BMJ Open"},{"issue":"3","key":"12032_CR21","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2352-3018(20)30307-6","volume":"8","author":"JE Haberer","year":"2021","unstructured":"Haberer JE, Bukusi EA, Mugo NR, Pyra M, Kiptinness C, Oware K, et al. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial. Lancet HIV. 2021;8(3):e130\u20137.","journal-title":"Lancet HIV"},{"issue":"2","key":"12032_CR22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/aje\/kwy228","volume":"188","author":"D Westreich","year":"2019","unstructured":"Westreich D, Edwards JK, Lesko CR, Cole SR, Stuart EA. Target validity and the hierarchy of study designs. Am J Epidemiol. 2019;188(2):438\u201343.","journal-title":"Am J Epidemiol"},{"key":"12032_CR23","unstructured":"Rao A. Pre-exposure prophylaxis for HIV prevention (PrEP) among young women at high risk for HIV in South Africa: longitudinal patterns of use and strategies to improve persistence. Johns Hopkins University; 2022."},{"issue":"3","key":"12032_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/10810730.2016.1261969","volume":"22","author":"KL Collier","year":"2017","unstructured":"Collier KL, Colarossi LG, Sanders K. Raising awareness of pre-exposure prophylaxis (PrEP) among women in new York city: community and provider perspectives. J Health Communication. 2017;22(3):183\u20139.","journal-title":"J Health Communication"},{"key":"12032_CR25","unstructured":"Carter A, Zhang M, Tram KH, Walters MK, Jahagirdar D, Brewer ED, et al. Global, regional,and national burden of HIV\/AIDS, 1990\u20132021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The Lancet HIV.2024;11(12):e807-e22."},{"issue":"3","key":"12032_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11904-020-00490-6","volume":"17","author":"JL Marcus","year":"2020","unstructured":"Marcus JL, Sewell WC, Balzer LB, Krakower DS. Artificial intelligence and machine learning for HIV prevention: emerging approaches to ending the epidemic. Curr HIV\/AIDS Rep. 2020;17(3):171\u20139.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"12032_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12874-021-01346-2","volume":"21","author":"CK Mutai","year":"2021","unstructured":"Mutai CK, McSharry PE, Ngaruye I, Musabanganji E. Use of machine learning techniques to identify HIV predictors for screening in sub-Saharan Africa. BMC Med Res Methodol. 2021;21(1):159.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"12032_CR28","doi-asserted-by":"publisher","first-page":"e59916","DOI":"10.2196\/59916","volume":"14","author":"M Jaiteh","year":"2025","unstructured":"Jaiteh M, Phalane E, Shiferaw YA, Phaswana-Mafuya RN. The application of machine learning algorithms to predict HIV testing in repeated adult Population\u2013Based surveys in South africa: protocol for a multiwave Cross-Sectional analysis. JMIR Res Protocols. 2025;14(1):e59916.","journal-title":"JMIR Res Protocols"},{"key":"12032_CR29","unstructured":"Judith N. Nyakanga. Machine learning and pre-exposure prophylaxis: a survey: https:\/\/gsconlinepress.com\/journals\/gscbps\/sites\/default\/files\/GSCBPS-2023-0182.pdf. 2023."},{"issue":"2","key":"12032_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/apc.2023.0117","volume":"38","author":"H Nagai","year":"2024","unstructured":"Nagai H, Ankomah A, Fuseini K, Adiibokah E, Semahegn A, Tagoe H. HIV pre-exposure prophylaxis uptake among high-risk population in sub-Saharan africa: A systematic review and meta-analysis. AIDS Patient Care STDs. 2024;38(2):70\u201381.","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"12032_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.glohj.2024.04.002","volume":"8","author":"E Moyo","year":"2024","unstructured":"Moyo E, Murewanhema G, Moyo P, Dzinamarira T, Ross A. The use of oral human immunodeficiency virus pre-exposure prophylaxis in pregnant and lactating women in sub-Saharan africa: considerations, barriers, and recommendations. Global Health J. 2024;8(2):41\u20135.","journal-title":"Global Health J"},{"issue":"1","key":"12032_CR32","doi-asserted-by":"publisher","first-page":"e70377","DOI":"10.1002\/hsr2.70377","volume":"8","author":"O Badru","year":"2025","unstructured":"Badru O, Hlongwa M, Adeagbo OA. Knowledge and awareness of Pre-Exposure prophylaxis among men in Sub\u2010Saharan africa: A scoping review protocol. Health Sci Rep. 2025;8(1):e70377.","journal-title":"Health Sci Rep"},{"issue":"2","key":"12032_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2478\/jtim-2023-0085","volume":"11","author":"Q Li","year":"2023","unstructured":"Li Q, Liu C, Li H. Suggestions on home quarantine and recovery of novel coronavirus patients. J Transl Int Med. 2023;11(2):111\u20134.","journal-title":"J Transl Int Med"},{"issue":"1","key":"12032_CR34","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1186\/s12889-024-19679-0","volume":"24","author":"D Yao","year":"2024","unstructured":"Yao D, Hill N, Brown B, Gule D, Chabane M, McIngana M, et al. The impact of COVID-19 restrictions on HIV prevention and treatment services for key populations in South africa: an interrupted time series analysis. BMC Public Health. 2024;24(1):2386.","journal-title":"BMC Public Health"},{"issue":"1","key":"12032_CR35","first-page":"e1","volume":"63","author":"R Kaswa","year":"2021","unstructured":"Kaswa R. The impact of the COVID-19 pandemic on accessing HIV care: A case report. S Afr Fam Pract (2004). 2021;63(1):e1\u20134.","journal-title":"S Afr Fam Pract (2004)"},{"key":"12032_CR36","doi-asserted-by":"crossref","unstructured":"Shim I, Rogowski L, Venketaraman V. Progress and recent developments in HIV vaccine research. Vaccines (Basel). 2025;13(7).","DOI":"10.3390\/vaccines13070690"},{"issue":"4","key":"12032_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2478\/jtim-2023-0122","volume":"11","author":"J Xie","year":"2023","unstructured":"Xie J, Ye F, Deng X, Tang Y, Liang JY, Huang X, et al. Circular RNA: A promising new star of vaccine. J Transl Int Med. 2023;11(4):372\u201381.","journal-title":"J Transl Int Med"},{"key":"12032_CR38","doi-asserted-by":"publisher","first-page":"1462648","DOI":"10.3389\/fpubh.2024.1462648","volume":"12","author":"TT Berhe","year":"2024","unstructured":"Berhe TT, Asfaw EA, Tedla GW. Assessment of acceptance and associated factors of HIV pre-exposure prophylaxis among commercial female sex workers in drop-in centers selected sub-cities of addis Ababa, Ethiopia. Front Public Health. 2024;12:1462648.","journal-title":"Front Public Health"},{"issue":"20","key":"12032_CR39","doi-asserted-by":"publisher","first-page":"e38199","DOI":"10.1097\/MD.0000000000038199","volume":"103","author":"C Elendu","year":"2024","unstructured":"Elendu C, Amaechi DC, Elendu ID, Elendu TC, Amaechi EC, Usoro EU, et al. Global perspectives on the burden of sexually transmitted diseases: A narrative review. Med (Baltim). 2024;103(20):e38199.","journal-title":"Med (Baltim)"},{"key":"12032_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1186\/1471-2458-11-727","volume":"11","author":"FN Samkange-Zeeb","year":"2011","unstructured":"Samkange-Zeeb FN, Spallek L, Zeeb H. Awareness and knowledge of sexually transmitted diseases (STDs) among school-going adolescents in europe: a systematic review of published literature. BMC Public Health. 2011;11:727.","journal-title":"BMC Public Health"},{"key":"12032_CR41","doi-asserted-by":"crossref","unstructured":"Hudu SA, Shinkafi SH, Jimoh AO. A critical review of diagnostic and prognostic markers of chronic hepatitis B infection. Med Rev (2021). 2024;4(3):225\u2009\u2013\u200934.","DOI":"10.1515\/mr-2024-0022"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12032-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:00:26Z","timestamp":1781614826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12032-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12032"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12032-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used secondary data from the Demographic and Health Surveys (DHS) conducted in eight sub-Saharan African countries. Permission to access the DHS datasets was obtained through an online request at\n                      \n                      , and a formal approval letter was issued. The DHS program obtained ethical clearance from relevant national ethics committees in each participating country as well as from the ICF Institutional Review Board. For all surveys, informed consent was obtained from participants, and issues of confidentiality, anonymity, and privacy were strictly observed. The present analysis was limited to secondary use of these de-identified DHS datasets solely for the objectives of this study. Therefore, no additional ethical clearance was required. All procedures were carried out in accordance with the ethical standards of the institutional and national research committees and with the Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1580"}}